Roche won't help to make Avastin available for AMD in France
This article was originally published in Scrip
Executive Summary
Roche is refusing to play any part in French government efforts to make its anticancer Avastin available for off-label use in wet AMD under a "temporary use recommendation" (RTU), saying that it goes against the product's labeling and that other therapeutic alternatives are already available.